Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial

Gharabawi, Georges M.; Greenspan, Andrew; Rupnow, Marcia F. T.; Kosik-Gonzalez, Colette; Bossie, Cynthia A.; Young Zhu; Kalali, Amir H.; Awad, A. George
January 2006
BMC Psychiatry;2006, Vol. 6, p45
Academic Journal
Background: Patient satisfaction with antipsychotic treatment is important. Limited evidence suggests that satisfaction is associated with symptom improvement and compliance. Predictors of patient satisfaction with antipsychotic medication were examined in a study of patients with a recent exacerbation of schizophrenia. Methods: Data are from a randomized, double-blind trial comparing risperidone (n = 152), quetiapine (n = 156), and placebo (n = 73). Medication Satisfaction Questionnaire (MSQ) was completed after 14 days of treatment and after 6 weeks at last study visit. Results: Medication satisfaction at both time points was significantly associated in multiple regression analysis with improvement on 3 Positive and Negative Syndrome Scale (PANSS) factor scores (positive symptoms p < .01; uncontrolled hostility/excitement, p < .0005; anxiety/depression, p < .04) and treatment with risperidone (p < .03); at day 14, significant association was also found with older age (p = .01). At both time points, predictor variables explained over 30% of the variance in medication satisfaction. Change in Hamilton Depression Scale, prolactin levels, sex, and reported adverse events of extrapyramidal symptoms, sedation, and movement disorders were not significant predictors of satisfaction. Lower level of medication satisfaction at day 14 was associated with earlier discontinuation in the trial at week 6 end point. A focused principal components analysis of PANSS factors and MSQ suggested that medication satisfaction relates to 3 groups of factors in descending order of magnitude: lower levels of (a) uncontrolled hostility/excitement, (b) positive symptoms, and (c) negative symptoms, disorganized thoughts, and anxiety/depression. Conclusion: Results give further support that treatment satisfaction is positively associated with symptom improvement, particularly psychotic symptoms, and suggest that satisfaction may also be related to compliance, as those who were more satisfied remained in the trial for a longer period of time.


Related Articles

  • Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. Ascher-Svanum, Haya; Baojin Zhu; Faries, Douglas; Landbloom, Ron; Swartz, Marvin; Swanson, Jeff // BMC Psychiatry;2006, Vol. 6, p8 

    Background: There is an ongoing debate over whether atypical antipsychotics are more effective than typical antipsychotics in the treatment of schizophrenia. This naturalistic study compares atypical and typical antipsychotics on time to all-cause medication discontinuation, a recognized index...

  • zotepine.  // Royal Society of Medicine: Medicines;2002, p580 

    This article presents information on zotepine, an antipsychotic drug which can be used for the treatment of schizophrenia. It is taken orally.

  • Improvement of Prefrontal Brain Function in Endogenous Psychoses Under Atypical Antipsychotic Treatment. Ehlis, Ann-Christine; Herrmann, Martin J.; Pauli, Paul; Stoeber, Gerald; Pfuhlmann, Bruno; Fallgatter, Andreas J. // Neuropsychopharmacology;Aug2007, Vol. 32 Issue 8, p1669 

    Typical and atypical antipsychotics are thought to exert their effects on different neurotransmitter pathways with specific action of atypical compounds on the prefrontal cortex, but studies directly investigating the effect of those drugs on neurophysiological measures of prefrontal brain...

  • Effects of long-term treatment with antipsychotics on serum leptin levels. Herrán, Andrés; García-Unzueta, María Teresa; Amado, José Antonio; de la Maza, María Teresa; Álvarez, Concepción; Vázquez-Barquero, José Luis // British Journal of Psychiatry;Jul2001, Vol. 179, p59 

    Background Abnormal regulation of the adipocyte-derived hormone leptin could play a role in body weight gain induced by antipsychotics. Aims To study the effects of long-term antipsychotic treatment on leptin levels in patients with schizophrenia. Method Serum leptin levels were determined in 59...

  • Attitudes to antipsychotic drugs and their side effects: a comparison between general practitioners and the general population. Helbling, Josef; Ajdacic-Gross, Vladeta; Lauber, Christoph; Weyermann, Ruth; Burns, Tom; Rössler, Wulf // BMC Psychiatry;2006, Vol. 6, p42 

    Background: Attitudes towards antipsychotic medication play an important part in the treatment for schizophrenia and related disorders. We aimed measuring general practitioners' attitudes to antipsychotic drugs and their adverse side effects and comparing these with the attitudes of the general...

  • Suicidality and second generation anytipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period. Barak, Y.; Mirecki, I.; Knobler, H. Y.; Natan, Z.; Aizenberg, D. // Psychopharmacology;2004, Vol. 175 Issue 2, p215 

    Discusses a study which assessed in a large cohort of schizophrenia patients the effects of exposure to second-generation antipsychotics on suicidality of patients suffering from schizophrenia or schizoaffective disorder. Situation wherein suicide is more likely to occur; Range of estimates of...

  • Alternative Complement Pathway in Schizophrenia. Boyajyan, Anna; Khoyetsyan, Aren; Chavushyan, Andranik // Neurochemical Research;Jun2010, Vol. 35 Issue 6, p894 

    In the present study, we evaluated functional activity of the alternative pathway of complement in schizophrenia by measuring the alternative pathway hemolytic activity (AH50) of complement as well as hemolytic activity of the complement C3 component (C3H50) in the blood of patients with...

  • Continuous antipsychotic use continues to impress.  // PharmacoEconomics & Outcomes News;7/25/2009, Issue 583, p9 

    The article discusses a study of the impact of continuous antipsychotic use on the quality of life (QOL) of patients with schizophrenia. The self-rated EuroQol-5D (EQ-5D) instrument was used to assess QOL. Results showed that after three years, the mean adjusted EQ-5D score increased from 0.57...

  • Case Histories Illustrating the Utility of Sertindole in Clinical Practice. Schuck, Peter; Ameele, Hans van den; Jaanson, Peeter; Ryckmans, Vincent; Hawley, Chris // CNS Drugs;2004 Supplement 2, Vol. 18, p31 

    Many conventional and atypical antipsychotic agents are available for the treatment of schizophrenia. Matching individual patients to the medication that suits them best is often a matter of trial and error. Controlled clinical trials and extensive post-marketing research have shown that the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics